Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
Authors
Keywords
-
Journal
OncoImmunology
Volume 4, Issue 4, Pages e1008866
Publisher
Informa UK Limited
Online
2015-05-28
DOI
10.1080/2162402x.2015.1008866
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Topical and oral bexarotene
- (2015) Courtney R. Schadt Dermatologic Therapy
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study
- (2014) A. Necchi et al. ANNALS OF ONCOLOGY
- Transient MEK inhibitor-associated retinopathy in metastatic melanoma
- (2014) U. Urner-Bloch et al. ANNALS OF ONCOLOGY
- Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer
- (2014) Y. Yamada et al. ANNALS OF ONCOLOGY
- A Safety and Feasibility Study of an Allogeneic Colon Cancer Cell Vaccine Administered with a Granulocyte–Macrophage Colony Stimulating Factor–Producing Bystander Cell Line in Patients with Metastatic Colorectal Cancer
- (2014) Lei Zheng et al. ANNALS OF SURGICAL ONCOLOGY
- Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
- (2014) L Bazzola et al. BRITISH JOURNAL OF CANCER
- Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy
- (2014) Jianliang Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy
- (2014) Christian P. Pallasch et al. CELL
- Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
- (2014) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Impact of myeloid cells on the efficacy of anticancer chemotherapy
- (2014) Laura Senovilla et al. CURRENT OPINION IN IMMUNOLOGY
- Targeting FAK in human cancer: from finding to first clinical trials
- (2014) Vita Golubovskaya Frontiers in Bioscience-Landmark
- High hydrostatic pressure induces immunogenic cell death in human tumor cells
- (2014) Jitka Fucikova et al. INTERNATIONAL JOURNAL OF CANCER
- Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
- (2014) Yoshihiko Ichikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial
- (2014) Helmut Oettle et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
- (2014) Caroline Robert et al. LANCET
- Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
- (2014) Yong Sang Hong et al. LANCET ONCOLOGY
- Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
- (2014) Thierry Conroy et al. LANCET ONCOLOGY
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
- (2014) Bernardo Tavora et al. NATURE
- An alternative DNA damage pathway to apoptosis in hematological cancers
- (2014) John M Luk et al. NATURE MEDICINE
- Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
- (2014) Francesca Cottini et al. NATURE MEDICINE
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways
- (2014) S. W. Morton et al. Science Signaling
- Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase
- (2014) Y. Liu et al. Science Translational Medicine
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- STK4 Inhibition Promotes YAP1-Mediated Apoptosis in Hematologic Cancers
- (2014) Cancer Discovery
- Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
- (2014) E. R. Lutz et al. Cancer Immunology Research
- Novel immune checkpoint blocker approved for the treatment of advanced melanoma
- (2014) Lorenzo Galluzzi et al. OncoImmunology
- Novel insights into the mechanism of action of lenalidomide
- (2014) Michaela Semeraro et al. OncoImmunology
- Why should we need the gut microbiota to respond to cancer therapies?
- (2014) Sophie Viaud et al. OncoImmunology
- Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
- (2014) Yuting Ma et al. OncoImmunology
- Trial Watch: Radioimmunotherapy for oncological indications
- (2014) Norma Bloy et al. OncoImmunology
- Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
- (2014) Abdul Qader Sukkurwala et al. OncoImmunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
- (2014) Shashi Gujar et al. OncoImmunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes
- (2014) Lidia Robert et al. OncoImmunology
- Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
- (2014) Encouse B Golden et al. OncoImmunology
- Trial Watch:
- (2014) Jonathan Pol et al. OncoImmunology
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Trial Watch
- (2014) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2014) Erika Vacchelli et al. OncoImmunology
- Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma
- (2013) D. J. Straus et al. ANNALS OF ONCOLOGY
- A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma
- (2013) Eileen M. OʼReilly et al. ANNALS OF SURGERY
- Cell-Death-Associated Molecular Patterns As Determinants of Cancer Immunogenicity
- (2013) Sylvain Ladoire et al. ANTIOXIDANTS & REDOX SIGNALING
- ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
- (2013) Abhishek D. Garg et al. Autophagy
- Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
- (2013) Abhishek D. Garg et al. BIOFACTORS
- Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205
- (2013) T Hoehler et al. BRITISH JOURNAL OF CANCER
- The stromal compartments in pancreatic cancer: Are there any therapeutic targets?
- (2013) Serena Lunardi et al. CANCER LETTERS
- CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
- (2013) Yuting Ma et al. CANCER RESEARCH
- Emerging roles of the microbiome in cancer
- (2013) S. J. Bultman CARCINOGENESIS
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Danger signalling during cancer cell death: origins, plasticity and regulation
- (2013) A D Garg et al. CELL DEATH AND DIFFERENTIATION
- Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
- (2013) A Ko et al. CELL DEATH AND DIFFERENTIATION
- Inducers of immunogenic cancer cell death
- (2013) Aleksandra M. Dudek et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Crosstalk between ER stress and immunogenic cell death
- (2013) Oliver Kepp et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Maspin influences response to doxorubicin by changing the tumor microenvironment organization
- (2013) Tiziana Triulzi et al. INTERNATIONAL JOURNAL OF CANCER
- Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients
- (2013) Patrizia Vici et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Decoding cell death signals in liver inflammation
- (2013) Catherine Brenner et al. JOURNAL OF HEPATOLOGY
- Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer
- (2013) Jun-Yang Lu et al. JOURNAL OF SURGICAL ONCOLOGY
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- (2013) Charles Butts et al. LANCET ONCOLOGY
- The role of the immune system in governing host-microbe interactions in the intestine
- (2013) Eric M Brown et al. NATURE IMMUNOLOGY
- Metabolic targets for cancer therapy
- (2013) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
- (2013) Chiara Riganti et al. PLoS One
- Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
- (2013) Hélène Bugaut et al. PLoS One
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Inhibition of the mevalonate pathway to override chemoresistance and promote the immunogenic demise of cancer cells
- (2013) Chiara Riganti et al. OncoImmunology
- Is there a future for adoptive cell transfer in melanoma patients?
- (2013) Michal J. Besser OncoImmunology
- Immune correlates of melanoma survival in adoptive cell therapy
- (2013) Agnes Fermin Lee et al. OncoImmunology
- Current trends of anticancer immunochemotherapy
- (2013) Erika Vacchelli et al. OncoImmunology
- Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells
- (2013) Mara Cirone et al. OncoImmunology
- Trial Watch: Lenalidomide-based immunochemotherapy
- (2013) Michaela Semeraro et al. OncoImmunology
- Adoptive T-cell transfer combined with a single low dose of total body irradiation eradicates breast tumors
- (2013) Nadine M. Lerret et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity
- (2013) Abhishek D Garg et al. OncoImmunology
- ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy
- (2013) Yuting Ma et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Immunogenic cell death in radiation therapy
- (2013) Lorenzo Galluzzi et al. OncoImmunology
- Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer
- (2013) Ben C. Creelan et al. OncoImmunology
- Trial watch
- (2013) Laurie Menger et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial
- (2012) U. O. Njiaju et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sorafenib Has Potent Antitumor Activity against Multiple Myeloma In Vitro, Ex Vivo, and In Vivo in the 5T33MM Mouse Model
- (2012) P. Kharaziha et al. CANCER RESEARCH
- Mitochondrial Control of Cellular Life, Stress, and Death
- (2012) Lorenzo Galluzzi et al. CIRCULATION RESEARCH
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
- (2012) Abhishek D Garg et al. EMBO JOURNAL
- Radiation Therapy to Convert the Tumor Into an In Situ Vaccine
- (2012) Silvia C. Formenti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial
- (2012) Sophie Gourgou-Bourgade et al. JOURNAL OF CLINICAL ONCOLOGY
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondria: master regulators of danger signalling
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Primary Effusion Lymphoma Cell Death Induced by Bortezomib and AG 490 Activates Dendritic Cells through CD91
- (2012) Mara Cirone et al. PLoS One
- An Immunosurveillance Mechanism Controls Cancer Cell Ploidy
- (2012) L. Senovilla et al. SCIENCE
- Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
- (2012) J. C. Arthur et al. SCIENCE
- Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
- (2012) L. Menger et al. Science Translational Medicine
- Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells
- (2012) P Kharaziha et al. Cell Death & Disease
- Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
- (2012) Lorenzo Galluzzi et al. Cell Reports
- Immunogenic Cell Death: Can It Be Exploited in PhotoDynamic Therapy for Cancer?
- (2012) Elisa Panzarini et al. Biomed Research International
- Activation of dendritic cells by tumor cell death
- (2012) Mara Cirone et al. OncoImmunology
- Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
- (2012) Mickaël Michaud et al. OncoImmunology
- Anticancer activity of cardiac glycosides
- (2012) Oliver Kepp et al. OncoImmunology
- The emergence of phox-ER stress induced immunogenic apoptosis
- (2012) Abhishek D. Garg et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma
- (2011) Mathieu Boulin et al. ANTI-CANCER DRUGS
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
- (2011) J. Fucikova et al. CANCER RESEARCH
- Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells
- (2011) Ilenia Pellicciotta et al. GYNECOLOGIC ONCOLOGY
- Dendritic Cell and Macrophage Heterogeneity In Vivo
- (2011) Daigo Hashimoto et al. IMMUNITY
- Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
- (2011) Yuting Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Induction of Immunogenic Apoptosis by Blockade of Epidermal Growth Factor Receptor Activation with a Specific Antibody
- (2011) Greta Garrido et al. JOURNAL OF IMMUNOLOGY
- Bacteria and host interactions in the gut epithelial barrier
- (2011) Hiroshi Ashida et al. Nature Chemical Biology
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown
- (2011) Abhishek D. Garg et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
- (2010) L. Galluzzi et al. CANCER RESEARCH
- Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
- (2010) G. Schiavoni et al. CANCER RESEARCH
- Decoding Cell Death Signals in Inflammation and Immunity
- (2010) Laurence Zitvogel et al. CELL
- Combining low-dose cyclophosphamide with GM-CSF–secreting prostate cancer immunotherapy enhances antitumor immune effects
- (2010) Emmanuel S Antonarakis et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial
- (2010) Alicia F.C. Okines et al. JOURNAL OF CLINICAL ONCOLOGY
- Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
- (2010) Faraaz B. Chekeni et al. NATURE
- Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
- (2010) I Martins et al. ONCOGENE
- Development of Monocytes, Macrophages, and Dendritic Cells
- (2010) F. Geissmann et al. SCIENCE
- JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis
- (2010) V Tomlinson et al. Cell Death & Disease
- Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation
- (2009) Abhishek D. Garg et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
- (2009) R. J. Rounbehler et al. CANCER RESEARCH
- Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
- (2009) Theocharis Panaretakis et al. EMBO JOURNAL
- About the cutaneous targets of bexarotene in CTCL patients
- (2009) Anne Chantal Knol et al. EXPERIMENTAL DERMATOLOGY
- Absence of modulation of CD4+CD25high regulatory T cells in CTCL patients treated with bexarotene
- (2009) Anne Chantal Knol et al. EXPERIMENTAL DERMATOLOGY
- Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
- (2009) Michael R. Elliott et al. NATURE
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
- (2008) J. Hoffmann et al. CANCER RESEARCH
- Ornithine Decarboxylase Inhibition by -Difluoromethylornithine Activates Opposing Signaling Pathways via Phosphorylation of Both Akt/Protein Kinase B and p27Kip1 in Neuroblastoma
- (2008) D.-L. T. Koomoa et al. CANCER RESEARCH
- PML, YAP, and p73 Are Components of a Proapoptotic Autoregulatory Feedback Loop
- (2008) Eleonora Lapi et al. MOLECULAR CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More